Join the Yasmin group to help and get support from people like you.
Yasmin News
FDA Medwatch Alert: Jubilant Cadista Pharmaceuticals Inc. Issues Voluntary Nationwide Recall of Drospirenone and Ethinyl Estradiol Tablets, USP, Due to Out-of-Specification Dissolution Test Results
July 23, 2019 – Salisbury, Maryland, Jubilant Cadista Pharmaceuticals Inc. is voluntarily recalling one lot of Drospirenone and Ethinyl Estradiol Tablets, USP, 3 mg/ 0.02mg, 28x3 Blister Pack/Carton...
FDA Medwatch Alert: Apotex Corp. Issues Voluntary Nationwide Recall of Drospirenone and Ethinyl Estradiol Tablets, USP, 28x3 Blister Pack/Carton Due to Possibility of Missing/Incorrect Tablet Arrangement
Weston, Florida, Apotex Corp . is voluntarily recalling four lots of Drospirenone and Ethinyl Estradiol Tablets, USP to the patient /user level. The four recalled lots of Drospirenone and Ethinyl...
FDA Medwatch Alert: Birth Control Pills Containing Drospirenone: Label Change-Products may be associated with a higher risk for blood clots
ISSUE: FDA has completed its review of recent observational (epidemiologic) studies regarding the risk of blood clots in women taking drospirenone-containing birth control pills.Based on this review,...
FDA Medwatch Alert: Birth Control Pills Containing Drospirenone: Possible Increased Risk of Blood Clots
[UPDATED 10-27-2011] FDA notified healthcare professionals of release of the final report of the FDA-funded study that evaluated the risk of blood clots in users of several different hormonal...
FDA Medwatch Alert: Birth Control Pills Containing Drospirenone: Possible Increased Risk of Blood Clots
[UPDATED 09/26/2011] FDA has not yet reached a conclusion, but remains concerned, about the potential increased risk of blood clots with the use of drospirenone-containing birth control pills. FDA...
FDA Medwatch Alert: Qualitest Pharmaceuticals Oral Contraceptives: Recall - Packaging Error
includes Cyclafem 7/7/7, Cyclafem 1/35, Emoquette, Gildess FE 1.5/30, Gildess FE 1/20, Orsythia, Previfem, Tri-Previfem ISSUE: Qualitest Pharmaceuticals issued a nationwide, retail-level recall of...
FDA Medwatch Alert: Birth Control Pills Containing Drospirenone: Possible Increased Risk of Blood Clots
ISSUE: FDA is aware of two newly published studies that evaluated the risk of venous thromboembolism (VTE) in women who use birth control pills that contain drospirenone. The two recently published...
FDA Approves Safyral - Oral Contraceptive That Also Raises Folate Levels
WAYNE, N.J., Dec. 16, 2010 /PRNewswire/ – Bayer HealthCare Pharmaceuticals, Inc. today announced the U.S. Food and Drug Administration (FDA) has approved a new oral contraceptive (OC), Safyral...
Further information
Related condition support groups
Premenstrual Dysphoric Disorder, Acne, Contraception, Birth Control